Neurobiology of Addiction

Core Concepts

The mesolimbic dopamine pathway: the reward highway

The VTA contains dopamine neurons whose axons project to the nucleus accumbens, often called the brain's reward center; its dopamine release signals "this experience is valuable; do it again." Natural reinforcers — food, water, social contact — also activate this pathway, so it is really a motivation system, not a pure pleasure system. Drugs hijack it with surges larger, faster, and more reliable than natural rewards: cocaine blocks the dopamine transporter, amphetamines reverse it, opioids inhibit GABAergic interneurons that brake the VTA, nicotine excites VTA neurons, alcohol acts on multiple receptors. Different drugs, one endpoint: excess accumbens dopamine.

The three-stage cycle: binge, withdrawal, craving

Addiction is often modeled as a three-stage cycle (associated with researchers such as Koob and Volkow). Binge/intoxication: the drug activates the reward circuit and tolerance develops, so more drug is needed for the same effect. Withdrawal/negative affect: when the drug leaves the system, reward tone drops below baseline while stress circuits (corticotropin-releasing factor, CRF, in the amygdala) overreact, producing anxiety and dysphoria — the "dark side" of addiction. Preoccupation/craving: drug cues trigger urges driven by the prefrontal cortex, hippocampus, and amygdala — relapse is most likely here, sometimes after years of abstinence.

Neuroadaptations: tolerance, sensitization, and allostasis

Repeated exposure changes the brain at synaptic and molecular levels. Tolerance means receptors downregulate, so the same dose produces less effect — the user needs more drug to feel normal, not high. Sensitization is the opposite change in a different circuit: the "wanting" system becomes hypersensitive to the drug and its cues, even as pleasure wanes. Together these represent allostasis: the brain settles at a new, drug-adapted equilibrium rather than its original set point — so withdrawal is not the mirror image of intoxication, and recovery requires slow re-adaptation.

Wanting vs. liking: incentive salience

Robinson and Berridge's liking/wanting distinction is central to addiction science. Liking is the actual pleasure a drug produces, mediated partly by opioid and endocannabinoid systems. Wanting (incentive salience) is the dopamine-mediated pull toward the drug. With repeated exposure they diverge: the dopamine system becomes sensitized, so the drug and its cues are wanted more intensely even as pleasure declines. This is why people chase drugs that no longer make them feel good — and why a bar, a song, or a stressful day can trigger craving and relapse.

Individual differences: genes, development, and environment

Not everyone who uses a drug becomes addicted. Genetics contributes substantially — twin and family studies commonly estimate heritability of addiction vulnerability around 40–60%. Development matters: the adolescent brain has a reactive reward system but an immature prefrontal cortex, and early onset of use is a strong risk factor. Environment shapes the trajectory through stress, trauma, social context, and drug availability; stress activates the same systems drugs engage, making it a powerful relapse trigger. These differences explain why the same substance is casual for one person and life-dominating for another.

Common Confusions